Jin Woong Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jin Woong Cho has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
Ji Woong Kim
Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea
7 shared publicationsMin A Yang
Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea
6 shared publicationsYoung Jae Lee
Department of Internal Medicine Presbyterian Medical Center Jeonju South Korea
6 shared publicationsSo Hee Yun
5 shared publicationsYong Keun Cho
Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea
5 shared publicationsGum Mo Jung
Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea
4 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (46) , e51530
Efficacy and safety of fexuprazan versus esomeprazole for healing of endoscopic submucosal dissection-induced artificial gastric ulcers: A multicenter, randomized, open-label, active-controlled trial
Background: Endoscopic submucosal dissection (ESD) is a standard treatment for gastric neoplasms but creates artificial ulcers requiring potent acid suppression. Potassium-competitive acid blockers (P-CABs) provide rapid and sustained acid suppression. This study compared the efficacy and safety of fexuprazan, a novel P-CAB, with esomeprazole for the healing of artificial gastric ulcers after ESD. Methods: This multicenter, randomized, open-label, active-controlled trial enrolled patients who underwent gastric ESD. Patients were randomly assigned (1:1) to receive either fexuprazan 40 mg or esomeprazole 40 mg once daily for 8 weeks. The primary endpoint was the ulcer healing rate at 8 weeks. Secondary endpoints included the incidence of delayed bleeding and adverse events. Results: Of 105 randomized patients, 90 were included in the full analysis set (FAS) and 85 in the per-protocol set (PPS). At 8 weeks, the complete healing rate (scar stage) in the PPS was 92.68% (38/41) in the fexuprazan group and 95.45% (42/44) in the esomeprazole group (95% confidence interval: 80.08–98.46 vs 84.53–99.44, P = .67), with an absolute difference of −2.77 percentage points (95% confidence interval: −15.32–8.85). Results were consistent in the FAS (93.02% vs 95.74%, 95% confidence interval: 80.94–98.54 vs 85.46–99.48, P = .67), with an absolute difference of −2.72 percentage points (95% confidence interval: −14.75–8.27). At 8 weeks, no patients in either group remained in the active stage. No delayed bleeding occurred in either group. Treatment-emergent adverse events were minimal and similar between groups (2.00% vs 4.08%, P > .62), with no serious adverse events. Conclusion: Fexuprazan 40 mg once daily showed no statistically significant difference from esomeprazole 40 mg for healing ESD-induced artificial gastric ulcers, with a favorable safety profile. These findings indicate that fexuprazan serves as a reasonable candidate for further investigation as a potential treatment option to proton pump inhibitors for post-ESD ulcer healing.
- 13 November 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (46) , e51530
Open AccessEfficacy and safety of fexuprazan versus esomeprazole for healing of endoscopic submucosal dissection-induced artificial gastric ulcers: A multicenter, randomized, open-label, active-controlled trial
Background: Endoscopic submucosal dissection (ESD) is a standard treatment for gastric neoplasms but creates artificial ulcers requiring potent acid suppression. Potassium-competitive acid blockers (P-CABs) provide rapid and sustained acid suppression. This study compared the efficacy and safety of fexuprazan, a novel P-CAB, with esomeprazole for the healing of artificial gastric ulcers after ESD. Methods: This multicenter, randomized, open-label, active-controlled trial enrolled patients who underwent gastric ESD. Patients were randomly assigned (1:1) to receive either fexuprazan 40 mg or esomeprazole 40 mg once daily for 8 weeks. The primary endpoint was the ulcer healing rate at 8 weeks. Secondary endpoints included the incidence of delayed bleeding and adverse events. Results: Of 105 randomized patients, 90 were included in the full analysis set (FAS) and 85 in the per-protocol set (PPS). At 8 weeks, the complete healing rate (scar stage) in the PPS was 92.68% (38/41) in the fexuprazan group and 95.45% (42/44) in the esomeprazole group (95% confidence interval: 80.08–98.46 vs 84.53–99.44, P = .67), with an absolute difference of −2.77 percentage points (95% confidence interval: −15.32–8.85). Results were consistent in the FAS (93.02% vs 95.74%, 95% confidence interval: 80.94–98.54 vs 85.46–99.48, P = .67), with an absolute difference of −2.72 percentage points (95% confidence interval: −14.75–8.27). At 8 weeks, no patients in either group remained in the active stage. No delayed bleeding occurred in either group. Treatment-emergent adverse events were minimal and similar between groups (2.00% vs 4.08%, P > .62), with no serious adverse events. Conclusion: Fexuprazan 40 mg once daily showed no statistically significant difference from esomeprazole 40 mg for healing ESD-induced artificial gastric ulcers, with a favorable safety profile. These findings indicate that fexuprazan serves as a reasonable candidate for further investigation as a potential treatment option to proton pump inhibitors for post-ESD ulcer healing.
- Open Access
- 10 September 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
Strategies for successful endoscopic submucosal dissection in difficult conditions of the upper gastrointestinal tract
Strategies for successful endoscopic submucosal dissection in difficult conditions of the upper gastrointestinal tract
- 10 September 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
Open AccessStrategies for successful endoscopic submucosal dissection in difficult conditions of the upper gastrointestinal tract
Strategies for successful endoscopic submucosal dissection in difficult conditions of the upper gastrointestinal tract
- Open Access
- 25 August 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
Successful endoscopic subserosal dissection for subepithelial tumor in gastric antrum
Successful endoscopic subserosal dissection for subepithelial tumor in gastric antrum
- 25 August 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
Open AccessSuccessful endoscopic subserosal dissection for subepithelial tumor in gastric antrum
Successful endoscopic subserosal dissection for subepithelial tumor in gastric antrum
- Open Access
- 30 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (2) , 245-253
Clinical efficacy of endoscopic resection for subepithelial tumors in the esophagogastric junction and gastric cardia: an observational study
Background/Aims: Gastric subepithelial tumors (SETs) located near the esophagogastric junction (EGJ) are difficult to treat surgically and endoscopically. This study aimed to evaluate the effectiveness and safety of endoscopic resection of SETs growing from the muscularis propria located in the EGJ and gastric cardia.Methods: This study included 26 consecutive patients who underwent endoscopic resection of 27 gastric SETs between November 2012 and May 2023.Results: Of the 27 gastric SETs, 3 and 24 were located in the EGJ and gastric cardia, respectively. The mean tumor size, operative time, and duration of hospitalization were 21 (6–52) mm, 35.4 (9–65) minutes, and 4.2 (3–7) days, respectively. Endoscopic resection of the SETs achieved an en bloc resection rate of 100% (27/27) and a complete resection rate of 88.9% (24/27). Pathological examination confirmed four gastrointestinal stromal tumors and 23 leiomyomas. No bleeding, peritonitis, or abdominal infection occurred after the endoscopic resections. Residual lesions were identified in three patients (11.1%). No recurrence was observed during follow-up (range, 3–24 months).Conclusions: SETs in the EGJ and gastric cardia can be resected effectively, even if they originate from the muscularis propria layer.
- 30 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (2) , 245-253
Open AccessClinical efficacy of endoscopic resection for subepithelial tumors in the esophagogastric junction and gastric cardia: an observational study
Background/Aims: Gastric subepithelial tumors (SETs) located near the esophagogastric junction (EGJ) are difficult to treat surgically and endoscopically. This study aimed to evaluate the effectiveness and safety of endoscopic resection of SETs growing from the muscularis propria located in the EGJ and gastric cardia.Methods: This study included 26 consecutive patients who underwent endoscopic resection of 27 gastric SETs between November 2012 and May 2023.Results: Of the 27 gastric SETs, 3 and 24 were located in the EGJ and gastric cardia, respectively. The mean tumor size, operative time, and duration of hospitalization were 21 (6–52) mm, 35.4 (9–65) minutes, and 4.2 (3–7) days, respectively. Endoscopic resection of the SETs achieved an en bloc resection rate of 100% (27/27) and a complete resection rate of 88.9% (24/27). Pathological examination confirmed four gastrointestinal stromal tumors and 23 leiomyomas. No bleeding, peritonitis, or abdominal infection occurred after the endoscopic resections. Residual lesions were identified in three patients (11.1%). No recurrence was observed during follow-up (range, 3–24 months).Conclusions: SETs in the EGJ and gastric cardia can be resected effectively, even if they originate from the muscularis propria layer.
- Open Access
- 16 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
Successful treatment of pneumosubperitoneum after gastric endoscopic subserosal dissection
Successful treatment of pneumosubperitoneum after gastric endoscopic subserosal dissection
- 16 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
Open AccessSuccessful treatment of pneumosubperitoneum after gastric endoscopic subserosal dissection
Successful treatment of pneumosubperitoneum after gastric endoscopic subserosal dissection
- Open Access
- 16 January 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 562-574
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers
Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, Woo Chul Chung, Suck Chei Choi, Si Hyung Lee, Tae Ho Kim, Dae Young Cheung, Gwang Ho Baik, Sun Moon Kim, Hang Lak Lee, Jeong Seop Moon, Cheol Woong Choi, Chongil Sohn, Kyoung Oh Kim, Byung-Wook Kim, Hye-Kyung Jung, Da Hyun Jung, Sung Soo Kim, Moo In Park, Ju Yup Lee, Gwang Ha Kim, Hee Seok Moon, Hoonjai Chun, Ki-Nam Shim, Woon Geon Shin, Chan Hyuk Park, Taeoh Kim, Sung Woo Jung, Hyunjin Kim, Sam Ryong Jee, Keemyung Lee, Yu Kyung Cho, Sung Chul Park, Jinwoong Cho, Chealwung Huh, Hyesoo Kwon, Jun Kim, John Kim, Jong-Jae Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250334
- 16 January 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 562-574
Open AccessRandomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers
Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, Woo Chul Chung, Suck Chei Choi, Si Hyung Lee, Tae Ho Kim, Dae Young Cheung, Gwang Ho Baik, Sun Moon Kim, Hang Lak Lee, Jeong Seop Moon, Cheol Woong Choi, Chongil Sohn, Kyoung Oh Kim, Byung-Wook Kim, Hye-Kyung Jung, Da Hyun Jung, Sung Soo Kim, Moo In Park, Ju Yup Lee, Gwang Ha Kim, Hee Seok Moon, Hoonjai Chun, Ki-Nam Shim, Woon Geon Shin, Chan Hyuk Park, Taeoh Kim, Sung Woo Jung, Hyunjin Kim, Sam Ryong Jee, Keemyung Lee, Yu Kyung Cho, Sung Chul Park, Jinwoong Cho, Chealwung Huh, Hyesoo Kwon, Jun Kim, John Kim, Jong-Jae Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250334
- Open Access
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 930-932
Successful endoscopic resection of a rectal schwannoma with mesorectal adventitial invasion
Successful endoscopic resection of a rectal schwannoma with mesorectal adventitial invasion
- 30 November 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (6) , 930-932
Open AccessSuccessful endoscopic resection of a rectal schwannoma with mesorectal adventitial invasion
Successful endoscopic resection of a rectal schwannoma with mesorectal adventitial invasion
- Open Access
- 28 April 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 19 (3) , 364-375
Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment
Hyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, Ok-Jae Lee, Gwang Ha Kim, Chang Seok Bang, Moo In Park, Jae Yong Park, Sun Moon Kim, Su Jin Hong, Joon Hyun Cho ,Shin Hee Kim, Hyun Joo Song, Jin Woong Cho, Sam Ryong Jee, Hyun Lim, Yong Hwan Kwon, Ju Yup Lee, Seong Woo Jeon, Seon-Young Park, Younghee Choe, Moon Kyung Joo, Dae-Hyun Kim, Jae Myung Park, Beom Jin Kim, Jong Yeul Lee, Tae Hoon Oh, Jae Gyu Kim, and Korean College of Helicobacter and Upper Gastrointestinal Research. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240489
- 28 April 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 19 (3) , 364-375
Open AccessKorean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment
Hyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, Ok-Jae Lee, Gwang Ha Kim, Chang Seok Bang, Moo In Park, Jae Yong Park, Sun Moon Kim, Su Jin Hong, Joon Hyun Cho ,Shin Hee Kim, Hyun Joo Song, Jin Woong Cho, Sam Ryong Jee, Hyun Lim, Yong Hwan Kwon, Ju Yup Lee, Seong Woo Jeon, Seon-Young Park, Younghee Choe, Moon Kyung Joo, Dae-Hyun Kim, Jae Myung Park, Beom Jin Kim, Jong Yeul Lee, Tae Hoon Oh, Jae Gyu Kim, and Korean College of Helicobacter and Upper Gastrointestinal Research. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240489
- Open Access
- 30 July 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (4) , 495-500
Prevalence and natural course of incidental gastric subepithelial tumors
Background/Aims: Gastric subepithelial tumors (SETs) are often encountered during the upper gastrointestinal endoscopic screening. We assessed the prevalence of gastric SETs and the risk factors for their progression.Methods: We reviewed the electronic medical records of 30,754 patients who underwent upper gastrointestinal endoscopic screening at our medical center between January 2013 and December 2016.Results: Among the 30,754 patients examined, 599 (1.94%) had gastric SETs. The prevalence increased with age and was 9.56% in patients aged ≥70 years. In total, 262 patients underwent serial endoscopy for more than 6 months. The median age was 68 years (interquartile range [IQR], 61–74), and the number of females was 167 (63.7%). During a median follow-up of 58 months (IQR, 38–75), 22 patients (8.4%) showed significant changes in tumor size. An irregular border (odds ratio, 4.623; 95% confidence interval, 1.093–19.558; p=0.037) was a significant risk factor for progression. Seven patients underwent surgical or endoscopic resections. The pathologies of gastric SETs included leiomyomas (n=3), gastrointestinal stromal tumors (n=2), and lipomas (n=2).Conclusions: The prevalence of gastric SETs increases with age. Most gastric SETs do not progress during long-term endoscopic examinations, and the risk of an increase in size is low in asymptomatic small SETs without irregular borders.
- 30 July 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (4) , 495-500
Open AccessPrevalence and natural course of incidental gastric subepithelial tumors
Background/Aims: Gastric subepithelial tumors (SETs) are often encountered during the upper gastrointestinal endoscopic screening. We assessed the prevalence of gastric SETs and the risk factors for their progression.Methods: We reviewed the electronic medical records of 30,754 patients who underwent upper gastrointestinal endoscopic screening at our medical center between January 2013 and December 2016.Results: Among the 30,754 patients examined, 599 (1.94%) had gastric SETs. The prevalence increased with age and was 9.56% in patients aged ≥70 years. In total, 262 patients underwent serial endoscopy for more than 6 months. The median age was 68 years (interquartile range [IQR], 61–74), and the number of females was 167 (63.7%). During a median follow-up of 58 months (IQR, 38–75), 22 patients (8.4%) showed significant changes in tumor size. An irregular border (odds ratio, 4.623; 95% confidence interval, 1.093–19.558; p=0.037) was a significant risk factor for progression. Seven patients underwent surgical or endoscopic resections. The pathologies of gastric SETs included leiomyomas (n=3), gastrointestinal stromal tumors (n=2), and lipomas (n=2).Conclusions: The prevalence of gastric SETs increases with age. Most gastric SETs do not progress during long-term endoscopic examinations, and the risk of an increase in size is low in asymptomatic small SETs without irregular borders.
- Open Access
- 30 May 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (3) , 329-331
Endoscopic resection penetrating the muscularis propria for gastric gastrointestinal stromal tumors: advances and challenges
Endoscopic resection penetrating the muscularis propria for gastric gastrointestinal stromal tumors: advances and challenges
- 30 May 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (3) , 329-331
Open AccessEndoscopic resection penetrating the muscularis propria for gastric gastrointestinal stromal tumors: advances and challenges
Endoscopic resection penetrating the muscularis propria for gastric gastrointestinal stromal tumors: advances and challenges